This content is machine translated PUBLICITY/ADVERTISEMENT Semaglutide – a GLP-1 analogue from a cardiovascular perspective. GLP-1 analogs are modeled on the natural GLP-1 (glucagon-like peptide 1). In studies, they show potent HbA1C control and weight reduction in patients with type 2 diabetes.1,2,* Their positive effect…
View Post 4 min This content is machine translated Diabetes Cases Cardio-renal protection as an important goal in type 2 diabetes. Cardio-renal protection is one of the most important goals in the management of type 2 diabetes mellitus. Therefore, SGED/SSED recommendations for the treatment of type 2 diabetes mellitus include a…
View Post 4 min This content is machine translated Type 2 diabetes Recommendations for the choice of therapy up to date In recent years, the treatment of type 2 diabetes has been expanded to include more and more options. However, this adds to the complexity of therapy selection. So what can…
View Post 4 min This content is machine translated Sponsored Content Semaglutide – a modern GLP-1 analogue in type 2 diabetes People with type 2 diabetes have too little endogenous GLP-1 (glucagon-like peptide 1). Semaglutide, which mimics natural GLP-1, can compensate.1 Like endogenous GLP-1, it normalizes blood glucose, supports weight loss,…
View Post 2 min This content is machine translated Diabetes Cases Diabetes treatment for increased risk to heart and kidney How should a typical diabetic patient, 55-year-old, obese, with hypertension, dyslipidemia, and reduced renal function be treated?
View Post 1 min This content is machine translated Online training Dementia: benefits of early treatment despite COVID-19 The Corona pandemic presents unique challenges for people with a psychiatric condition. Prof. Dr. med. Egemen Savaskan from the Psychiatric University Hospital Zurich informs about the state of the art…
View Post 6 min This content is machine translated Type 2 diabetes Better quality of life thanks to modern diabetes therapy The cardiovascular benefit of SGLT2 inhibitors and GLP1 analogues is now considered established, and non-diabetics may also benefit. For optimal results, therapy should be tailored to individual patient characteristics.
View Post 4 min This content is machine translated Reflux in the age of COVID-19 When to see a specialist? Under the impact of the current COVID-19 pandemic and its associated restrictions, many patients are reluctant to see a doctor for health problems. As a result, for example, widespread troublesome…
View Post 2 min This content is machine translated Biologics for psoriasis Head-to-head study delivers exciting results Interleukin-23 and interleukin-17A play an important role in the inflammatory process of plaque psoriasis. A comparison of two agents directed against these targets in moderate to severe plaque psoriasis led…
View Post 4 min This content is machine translated Diabetes Cases Prevention of cardiovascular events in type 2 diabetes. Type 2 diabetes mellitus (T2DM) is associated with a greatly increased risk of cardiovascular disease [1]. The joint management of T2DM and the cardiovascular risks has therefore come into focus…
View Post 4 min This content is machine translated Reflux Cases What to do if there is a fire when setting down? A 43-year-old patient discontinues the PPI as discussed with the physician after 14 days of therapy. The complaints return so violently that he continues the therapy on his own authority.…
